PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 101 - 130 of 130
- Multiple Myeloma - Exploring new targets for multiple drug therapy
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs
- Head and Neck Cancer
- How to Conduct Clinical Trials in China
- The Cancer Market Outlook to 2012
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- Cancer Cell Therapy Markets
- Companion Diagnostics in Personalized Medicine and Cancer Therapy
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- The Worldwide Market for Cancer Diagnostics
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Pipeline Insight: Non-Small Cell Lung Cancer - emerging therapies
- Pipeline Insight: Breast Cancer - Targeted Therapies, New Cytotoxics and Vaccines
- Outsourcing in Drug Discovery
- Companion Diagnostics Markets
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Oncology Market Leaders - Analyses and Outlook, Market Report 2008-2023
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Cancer Drug Resistance 2008
- Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbust
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types
- Stakeholder Opinions: Vaccine adjuvants
- GPCR Screening & Profiling Trends 2008
- Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development